Ocular Amnion is the dedicated ocular division of RevoGen Biologics, a leader in high-quality allograft biologics. We deliver RevoShield+™ with RevoGen's rigorous standards: stringent donor screening, state-of-the-art clean-room processing, routine quality audits, and physician-first relationships. Eye care professionals trust us for safe, consistent, effective amniotic membrane therapy that improves patient outcomes in dry eye syndrome, corneal defects, and epithelial impairments.
FDA Approved
FDA-cleared Class II medical device with proven safety
